Cardiac Monitors in Colorado

C.R. Bard (now part of BD) is a diversified global medical technology company operating through multiple business segments: BD Interventional, BD Life Sciences, and BD Medical. The company manufactures and distributes an extensive portfolio of medical devices, consumables, and diagnostic solutions across vascular access, medication delivery, infection prevention, laboratory diagnostics, surgical instruments, and specialty medical equipment. Through the Medivance acquisition (2011), Bard offers the Arctic Sun™ Targeted Temperature Management system for precise patient temperature control in critical care settings. The company serves hospitals, healthcare systems, clinical laboratories, and other healthcare facilities with products spanning syringes and needles, catheters (central and peripheral), infusion systems, surgical mesh and grafts, diagnostic culture media, molecular testing systems, blood collection products, stents, and specialty equipment for urology, cardiology, gynecology, and interventional medicine. With thousands of SKUs across therapeutic areas including vascular surgery, gastrointestinal care, wound management, and microbiology solutions, Bard functions as a comprehensive B2B medical device and consumables supplier.

Newman Medical designs and manufactures Doppler ultrasound systems and vascular testing devices for non-invasive physiological assessment of peripheral arterial disease, venous insufficiency, and fetal monitoring. Founded in 2005 and based in the Denver, Colorado area, the company specializes in three primary product lines: DigiDop arterial Dopplers for vascular assessment, simpleABI ankle-brachial index (ABI) systems for PAD diagnosis, and DigiDop Fetal Dopplers for prenatal care. All products are American-designed and manufactured in-house, with interchangeable probes for versatility across examination sites. DigiDop systems feature high-sensitivity blood flow detection technology and are backed by industry-leading 5-year warranties covering parts, labor, and accidental breakage. The simpleABI systems are PC-based, user-friendly platforms offering cost-effective, reimbursable PAD diagnosis with 2-year comprehensive warranty. Newman Medical serves healthcare providers through direct sales and an established network of national and international distributors. The company emphasizes responsive technical support from vascular specialists and quality control throughout the manufacturing process. Products are used in clinical settings requiring rapid, accurate vascular diagnosis and prenatal monitoring without invasive procedures.

Fischer Medical manufactures cardiac electrophysiology stimulation equipment with over 40 years of market presence. The company traces its heritage to the H.G. Fischer Company, founded in 1910 in Chicago as the oldest manufacturer of X-ray imaging devices in the U.S. Fischer entered cardiac electrophysiology in the 1970s with X-ray systems and expanded into recording and monitoring systems. In 1992, the acquisition of Bloom Associates Ltd. (Reading, PA) added stimulator capabilities to the product line. Fischer's core offering comprises the Bloom® DTU-215B and Bloom² lines of EP cardiac stimulators, which serve electrophysiology labs globally. The Bloom® Classic DTU-215B is a four-channel stimulator recognized as the gold standard in EP labs for over 40 years, with operator-controlled pacing protocols. The Bloom² offers a modernized touchscreen interface, tactile controls, and compact footprint while maintaining pre-programmable protocol setups. Both systems are designed for use in cardiac electrophysiology procedures, including pacing and arrhythmia assessment. Fischer Medical operates from Wheat Ridge, Colorado, and provides sales, parts, and technical support services. The company maintains emergency technical support lines for multiple U.S. regions, indicating a service-oriented business model supporting installed equipment in clinical environments.

OSYPKA is a multinational medical device manufacturer with over 45 years of experience specializing in interventional cardiology and pediatric cardiology solutions. The company develops and manufactures active implants and catheters for cardiac applications, including pacemaker electrodes and radiofrequency ablation systems. OSYPKA operates as both a branded product manufacturer and a contract development and manufacturing organization (CDMO) serving global medical device partners with turnkey solutions for implantable devices and catheters. The company pioneered the first fracture-resistant implantable pacemaker electrode and has developed innovative technologies in cardiac intervention and neurostimulation. OSYPKA maintains manufacturing and quality capabilities across three main locations: Germany (headquarters in Rheinfelden), the USA (Longmont, Colorado), and the Czech Republic (Odry). The organization holds ISO 13485:2016 certification, EU Quality Management System certification under MDR (Medical Device Regulation), and Czech Quality Management System certification. The company serves interventional cardiologists, hospital systems, and medical device OEMs worldwide with both proprietary product lines and custom manufacturing solutions.